Stock Events

Stock Events

LakeShore Biopharma 

$0.01
0
+$0+0% Wednesday 13:08

Statistics

Day High
0.01
Day Low
0.01
52W High
0.01
52W Low
0.01
Volume
50,000
Avg. Volume
-
Mkt Cap
207,670
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17AprExpected
Q4 0
Q4 2025
Next
-0.17
0.17
0.5
0.83
Expected EPS
N/A
Actual EPS
N/A

Financials

-75.59%Profit Margin
Unprofitable
2020
2021
2022
2023
158.59MRevenue
-119.88MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LSBWF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap10.61B
Moderna, Inc. competes in the biotechnology and pharmaceuticals space, focusing on mRNA-based therapies, similar to YS Biopharma's focus on innovative biopharmaceuticals.
BioNTech
BNTX
Mkt Cap24.99B
BioNTech SE operates in the field of mRNA technology for developing vaccines and therapeutics, directly competing with YS Biopharma's biopharmaceutical innovations.
Novavax
NVAX
Mkt Cap1.36B
Novavax, Inc. is involved in the development of vaccines for infectious diseases, competing with YS Biopharma's focus on therapeutic solutions.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a large pharmaceutical company with a broad product portfolio that includes biopharmaceuticals, competing in various therapeutic areas with YS Biopharma.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceuticals sector, offering a wide range of products that compete with YS Biopharma's biopharmaceutical solutions.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC is a global biopharmaceutical company focusing on the discovery, development, and commercialization of prescription medicines, including those in areas where YS Biopharma operates.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc is a healthcare company that researches and develops pharmaceuticals, vaccines, and consumer healthcare products, competing with YS Biopharma in the biopharmaceutical field.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is known for its high-quality medicines, vaccines, biologic therapies, and animal health products, competing across several of YS Biopharma's key areas.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG engages in the pharmaceuticals and diagnostics business, directly competing with YS Biopharma in the development of innovative therapeutic solutions.
Sanofi
SNY
Mkt Cap124.45B
Sanofi operates globally in pharmaceuticals, covering a broad range of therapeutic areas and competing with YS Biopharma in the biopharmaceutical and vaccine sectors.

About

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
Show more...
CEO
Dr. Yuan Liu Ph.D.
Employees
758
Country
US
ISIN
KYG9845F1173

Listings

OTC Link
US
LSBCF
OTC Link
US
LSBWF
XNAS
US
LSB

0 Comments

Share your thoughts

FAQ

What is LakeShore Biopharma stock price today?▼
The current price of LSBWF is $0.01 USD — it has increased by +0% in the past 24 hours. Watch LakeShore Biopharma stock price performance more closely on the chart.
What is LakeShore Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange LakeShore Biopharma stocks are traded under the ticker LSBWF.
What is LakeShore Biopharma market cap?▼
Today LakeShore Biopharma has the market capitalization of 207,670
When is the next LakeShore Biopharma earnings date?▼
LakeShore Biopharma is going to release the next earnings report on April 17, 2026.
What is LakeShore Biopharma revenue for the last year?▼
LakeShore Biopharma revenue for the last year amounts to 158.59M USD.
What is LakeShore Biopharma net income for the last year?▼
LSBWF net income for the last year is -119.88M USD.
How many employees does LakeShore Biopharma have?▼
As of April 01, 2026, the company has 758 employees.
When did LakeShore Biopharma complete a stock split?▼
LakeShore Biopharma has not had any recent stock splits.
Where is LakeShore Biopharma headquartered?▼
LakeShore Biopharma is headquartered in Beijing, US.